GSK Investigational Site

Sherman Oaks, California 91403

2 studies enrolling now · 9 studies all time

What they study most

Alzheimer's Disease, Asthma, Bipolar Disorder, Chickenpox, Epilepsy, Irritable Bowel Syndrome, Major Depressive Disorder (MDD), Migraine Disorders, Migraine, Acute, Schizophrenia

Studies at this site

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) — Recruiting now
• A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age — Recruiting now
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
• Lethargic Depression Study — Completed
• Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia — Completed
• Advair Pediatric Once-Daily — Completed
• Bipolar Study in Adults at Least 18 Years of Age — Completed
• TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults — Completed